Inactive Instrument
Pandion Therapeutics, Inc. Share Price
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 31/07/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/21 | Tender | Director | 91,738 | 0.3108% | ||
| 01/04/21 | Polaris Growth Management LLC
| Tender | Company | 3,201,422 | 10.8465% | |
| 01/04/21 | Tender | Executive/Senior Manager | 189,780 | 0.6430% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 1.7B | |
| -6.60% | -8.56% | +42.79% | +64.16% | 65B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 51.19B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 51.2B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 43.93B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 41.96B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 38.14B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 33.24B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.2B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.03B | |
| Average | -1.64% | -1.67% | +43.33% | +85.71% | 41.32B | |
| Weighted average by Cap. | -2.29% | -1.21% | +43.56% | +88.58% |
Employees
56
